Ionis Pharmaceuticals
IONS
IONS
361 hedge funds and large institutions have $5.6B invested in Ionis Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 106 increasing their positions, 137 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less capital invested
Capital invested by funds: $7.29B → $5.6B (-$1.7B)
34% less call options, than puts
Call options by funds: $30.9M | Put options by funds: $46.5M
43% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 61
Holders
361
Holding in Top 10
6
Calls
$30.9M
Puts
$46.5M
Top Buyers
| 1 | +$89.7M | |
| 2 | +$60.1M | |
| 3 | +$15.1M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.4M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.86M |
Top Sellers
| 1 | -$130M | |
| 2 | -$24.8M | |
| 3 | -$16.6M | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$16.5M |
| 5 |
SI
Scout Investments
Kansas City,
Missouri
|
-$15.6M |